A large multi-cohort study that screened the transcriptomic landscape in PC unveiled several novel mRNAs (ABCC5, MPZL1, CCNE1, and RASAL2) as prognostic biomarkers involved in PC progression into metastatic disease [64]. Here, RASAL2 is linked to pachyonychia congenita.